Immuneering Corp <IMRX.O>: Needham raises target price to $18 from $11
IMRX•Related News
Capital One defeats lawsuit alleging excessive credit-card rates
COF•
Anixa Biosciences director Lewis H. Titterton Jr acquires 12,000 common shares valued at $41,640
ANIX•
Nasdaq trade halt continues <PC.O> reason not available at 07:50 PM
PC•
ServisFirst Bancshares Q2 EPS USD 1.57
SFBS•
Gold gains as hopes for US-Iran diplomacy cool oil price rally
GLD•